
Fechner discusses the 2-year data from an open-label extension of the CAHtalyst Pediatric study, maintaining substantial glucocorticoid dose lowering.

Patricia Fechner, MD, is the attending physician at Seattle Children’s Hospital and a professor of pediatrics at the University of Washington School of Medicine.

Fechner discusses the 2-year data from an open-label extension of the CAHtalyst Pediatric study, maintaining substantial glucocorticoid dose lowering.